Press "Enter" to skip to content

New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT

Annual Drug Patent Expirations for COMBIVENT+RESPIMAT
Annual Drug Patent Expirations for COMBIVENT+RESPIMAT

Combivent Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.

This drug has one hundred and fifty-four patent family members in forty-four countries.

The generic ingredient in COMBIVENT RESPIMAT is albuterol sulfate; ipratropium bromide. One supplier is listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Boehringer Ingelheim drug COMBIVENT RESPIMAT
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions